Supplementary Tables from The IGF2BP3–COPS7B Axis Facilitates mRNA Translation to Drive Colorectal Cancer Progression

Supplementary Tables from The IGF2BP3–COPS7B Axis Facilitates mRNA Translation to Drive Colorectal Cancer Progression

<p>Supplementary Tables</p>

Zapisane w:

Opis bibliograficzny
1. autor:	Jing Tang (17314958) (author)
Kolejni autorzy:	Shuoshuo Wang (17314961) (author), Mingjiao Weng (17314964) (author), Qingyu Guo (17314967) (author), Lili Ren (17314970) (author), Yan He (17314973) (author), Zihan Cui (17314976) (author), Mingqi Cong (17314979) (author), Minglu Qin (17314982) (author), Jia Yu (11566524) (author), Rui Su (17314985) (author), Xiaobo Li (17314988) (author)
Wydane:	2025
Hasła przedmiotowe:	Cancer Cancer Biology Tumor Biology Molecular and Cellular Biology Carcinogenesis Gastrointestinal Cancers Colorectal cancer Gene Regulation Posttranscriptional and translational control Oncogenes & Tumor Suppressors Oncogenes Progression, Invasion & Metastasis Tumor progression
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Table S1 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
od: Xun-Xi Lu (14952883)
Wydane: (2025)

Table S2 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
od: Xun-Xi Lu (14952883)
Wydane: (2025)

Table S3 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
od: Xun-Xi Lu (14952883)
Wydane: (2025)

Table S7 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
od: Xun-Xi Lu (14952883)
Wydane: (2025)

Table S8 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
od: Xun-Xi Lu (14952883)
Wydane: (2025)

Supplementary Table S3 from The Polyamine–Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma
od: Shima Nakanishi (16336496)
Wydane: (2025)

Supplementary Table S4 from The Polyamine–Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma
od: Shima Nakanishi (16336496)
Wydane: (2025)

Table S2 from MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
od: Cheng-Kai Wang (14963880)
Wydane: (2025)

Supplementary table S2 from SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
od: Leon P. Loevenich (14963948)
Wydane: (2025)

Supplementary table S3 from SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
od: Leon P. Loevenich (14963948)
Wydane: (2025)

Supplementary table S4 from SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
od: Leon P. Loevenich (14963948)
Wydane: (2025)

Supplementary video file from SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
od: Leon P. Loevenich (14963948)
Wydane: (2025)

Supplementary Table S1 from A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer
od: Nan Ding (15321526)
Wydane: (2025)

Supplementary Table S2 from A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer
od: Nan Ding (15321526)
Wydane: (2025)

Supplementary Table 1 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
od: Duygu Kuzuoglu-Ozturk (14960213)
Wydane: (2025)

Supplementary Table 2 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
od: Duygu Kuzuoglu-Ozturk (14960213)
Wydane: (2025)

Supplementary Table 3 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
od: Duygu Kuzuoglu-Ozturk (14960213)
Wydane: (2025)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
od: Min Wei (16918572)
Wydane: (2025)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
od: Min Wei (16918572)
Wydane: (2025)

Supplemental Tables 1-8 from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated <i>SPP1</i><sup>+</sup> Macrophages and Fibroblasts
od: Anuja Sathe (15028097)
Wydane: (2025)

Supplementary Table 1 from ESRRB Inhibits the TGFβ Signaling Pathway to Drive Cell Proliferation in Cervical Cancer
od: Qin-Shu Li (16990832)
Wydane: (2025)

Supplementary Table 2 from ESRRB Inhibits the TGFβ Signaling Pathway to Drive Cell Proliferation in Cervical Cancer
od: Qin-Shu Li (16990832)
Wydane: (2025)

Supplementary Figure S1 from G-CSF Is a Novel Mediator of T-Cell Suppression and an Immunotherapeutic Target for Women with Colon Cancer
od: Anita L. Ray (15313398)
Wydane: (2025)

Supplementary Figure S2 from G-CSF Is a Novel Mediator of T-Cell Suppression and an Immunotherapeutic Target for Women with Colon Cancer
od: Anita L. Ray (15313398)
Wydane: (2025)

Supplementary Table 1 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 2 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 3 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 4 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 7 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 8 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 9 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Figure 1 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Wydane: (2025)

Figure 2 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Wydane: (2025)

Figure 3 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Wydane: (2025)

Figure 4 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Wydane: (2025)

Figure 5 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Wydane: (2025)

Figure 6 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Wydane: (2025)

Table 1 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Wydane: (2025)

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
od: Xiaodong Shu (16721586)
Wydane: (2025)

Cannot write session to /tmp/vufind_sessions/sess_g0jmkf7ucg8dtda8id8gfef530